SCHEMBL25632147

SCHEMBL25632147

O=C1CCN(c2ccc(N3CCN(C4CCC5(CCNCC5)CC4)CC3)cc2)C(=O)N1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DDB1 Q16531 8/20 0.47
CRBN Q96SW2 8/20 0.47
USP2 O75604 2/20 0.41
CYP2D6 P10635 2/20 0.41
GRIN2B Q13224 1/20 0.36
L3MBTL3 Q96JM7 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
KMT2A Q03164 3/20 0.34
MEN1 O00255 2/20 0.34
HRH3 Q9Y5N1 1/20 0.34
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30525346 0.99 DDB1 (0.46) DDB1CRBNUSP2CYP2D6GRIN2B
SCHEMBL25263523 0.89 CRBN (0.48) DDB1CRBNUSP2CYP2D6HRH3
SCHEMBL24678276 0.89 DDB1 (0.52) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
Hydrochloric Acid SCHEMBL30525354 0.88 DDB1 (0.51) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
SCHEMBL25222977 0.87 DDB1 (0.50) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
Hydrochloric Acid SCHEMBL31230691 0.86 DDB1 (0.49) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
SCHEMBL25631809 0.85 DDB1 (0.48) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
Hydrochloric Acid SCHEMBL31230703 0.84 DDB1 (0.47) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
SCHEMBL25631761 0.81 CRBN (0.55) DDB1CRBNGRIN2BL3MBTL3L3MBTL1
Fluoroacetate SCHEMBL30525355 0.81 DDB1 (0.41) DDB1CRBNUSP2CYP2D6L3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129074-A1 CHIMERIC COMPOUND FOR TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF SHANGHAI HENGRUI PHARMACEUTICAL CO., LTD. (CN) 2025-04-24 US disclosed
WO-2023093845-A1 CHIMERIC COMPOUND FOR TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-06-01 WO disclosed
WO-2023093845-A1 CHIMERIC COMPOUND FOR TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF 江苏恒瑞医药股份有限公司 2023-06-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129074-A1 CHIMERIC COMPOUND FOR TARGETED DEGRADATION OF ANDROGEN RECEPTOR PROTEIN, PREPARATION METHOD THEREFOR, AND MEDICAL USE THEREOF AR, NR5A1, CYP17A1 DDB1 4432/4885CRBN 743/4885USP2 2339/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.